Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Published 2018 View Full Article

Authors

Keywords

Journal

Arthritis & Rheumatology

Volume -, Issue -, Pages -

Publisher

Wiley

Online

2018-05-07

DOI

10.1002/art.40547

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Arthritis & Rheumatology

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Create your own webinar